This list is an analysis based on recent market events. It's not an investment recommendation.
Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in developing diagnostic instruments and associated consumables for infection detection. The company crafts advanced in vitro diagnostic platforms, specifically engineered to identify infectious diseases. A key product is ASTar, an innovative system designed to rapidly assess antibiotic susceptibility in positive blood cultures. Q-linea's overarching mission is to deliver cutting-edge solutions to healthcare professionals.
Show more...
FAQ
What is Q-Linea AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Q-Linea AB stocks are traded under the ticker 3F8.MU.
When is the next Q-Linea AB earnings date?▼
Q-Linea AB is going to release the next earnings report on October 30, 2026.
What is Q-Linea AB revenue for the last year?▼
Q-Linea AB revenue for the last year amounts to 1.01M EUR.
What is Q-Linea AB net income for the last year?▼
3F8.MU net income for the last year is -16.64M EUR.
How many employees does Q-Linea AB have?▼
As of August 24, 2026, the company has 70 employees.
In which sector is Q-Linea AB located?▼
Q-Linea AB operates in the Health & Wellness sector.
When did Q-Linea AB complete a stock split?▼
The last stock split for Q-Linea AB was on July 14, 2025 with a ratio of 1:1000.
Where is Q-Linea AB headquartered?▼
Q-Linea AB is headquartered in Uppsala, Sweden.